Showing results (361-370 of 725) with videos related to
Sort By:
Pageof 73
Journal of Cardiovascular Pharmacology|September 1, 1988
Atrial natriuretic peptide administered as intravenous infusion or bolus injection to patients with liver cirrhosis and ascitesA Petrillo, U Scherrer, J J Gonvers, et al.Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|June 1, 1996
Cardioprotective potential of angiotensin converting enzyme inhibitorsI Gavras, H GavrasJournal of Human Hypertension|April 23, 2002
Angiotensin II as a cardiovascular risk factorI Gavras, H GavrasQuarterly Journal of Experimental Physiology (Cambridge, England)|July 1, 1984
Cardiovascular responses in the diabetic ratF Charocopos, H GavrasThe New England Journal of Medicine|May 4, 1978
Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in manH Gavras, H R Brunner, G A Turini, et al.Journal of Cardiovascular Pharmacology|January 1, 1987
Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteersJ Nussberger, T Fasanella d'Amore, M Porchet, et al.Journal of Cardiovascular Pharmacology|September 1, 1991
Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humansE Camenzind, J Nussberger, L Juillerat, et al.The Journal of Biological Chemistry|November 25, 1992
Promoter region of the human alpha 2A adrenergic receptor geneD E Handy, H GavrasHypertension (Dallas, Tex. : 1979)|April 1, 1996
Evidence for cell-specific regulation of transcription of the rat alpha2A-adrenergic receptor geneD E Handy, H GavrasThe American Journal of Cardiology|May 4, 2001
Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular diseaseH R BrunnerPageof 73